Loading...
Micro Labs Limited — Celecoxib Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #5 for Celecoxib · $6.8M export value · DGFT Verified
Micro Labs Limited is the #5 Indian exporter of Celecoxib with $6.8M in export value and 201 verified shipments. Micro Labs Limited holds a 5.1% market share in Celecoxib exports across 19 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $1.9M | 53 | 33.6% |
| UNITED STATES | $884.6K | 28 | 15.3% |
| GERMANY | $703.8K | 34 | 12.2% |
| UNITED KINGDOM | $417.5K | 14 | 7.2% |
| ALGERIA | $386.5K | 9 | 6.7% |
| JORDAN | $383.0K | 13 | 6.6% |
| IRAQ | $351.0K | 11 | 6.1% |
| NETHERLANDS | $198.3K | 5 | 3.4% |
| UKRAINE | $115.2K | 3 | 2.0% |
| MALTA | $82.7K | 2 | 1.4% |
Micro Labs Limited exports Celecoxib to 20 countries. The largest destination is FRANCE accounting for 33.6% of Micro Labs Limited's Celecoxib shipments, followed by UNITED STATES (15.3%) and GERMANY (12.2%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| E.P.DIS | FRANCE | $1.2M | 36 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $585.8K | 20 |
| EVERSANA LIFE SCIENCE SERVICES, LLC | UNITED STATES | $561.3K | 16 |
| E P DIS | FRANCE | $437.0K | 11 |
| MICRO LABS GMBH | GERMANY | $385.7K | 9 |
| MSK PHARMALOGISTIC GMBH |
India exported $62.9M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. Micro Labs Limited contributes $6.8M to this total, accounting for 5.1% of India's Celecoxib exports. Micro Labs Limited ships Celecoxib to 20 countries through 37 buyers.
Micro Labs Limited's average Celecoxib shipment value is $33.8K per consignment, based on 201 shipments totaling $6.8M. The largest destination is FRANCE (33.6% of Micro Labs Limited's Celecoxib exports).
Micro Labs Limited ranks #5 among 326 Indian Celecoxib exporters with a 5.1% market share. The top 3 exporters are ALEMBIC PHARMACEUTICALS LIMITED ($12.2M), CIPLA LIMITED ($12.2M), MACLEODS PHARMACEUTICALS LTD ($9.2M). Micro Labs Limited processed 201 shipments to 19 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CELECOXIB CAPSULES 100 MG ANDA NO. 20477 | $209.6K | 5 |
| CELECOXIB MICRO LABS 200 MG HARTKAPSILN | $145.0K | 3 |
| CELEBID 200 ( (CELECOXIB 200MG CAPSULES)) ( 3X10S ) ( QTY- 24696.000 )PCS | $141.4K | 3 |
| CELEBID 200 ( (Celecoxib 200mg Capsules) | $113.6K | 4 |
| COXIB 200 (CELECOXIB CAPSULES 200MG) (3X10S) - TAX INV NO: 712202997 DT: 16.05.2024 | $101.0K | 3 |
| CELEBID 200 (CELECOXIB 200MG CAPSULES) ( | $100.0K | 2 |
| DENOXIB 200 ( (Celecoxib 200mg Capsules)) ( 3X10S ) ( QTY- 32283.000 ) | $100.0K | 2 |
| CELEBID 100 MG ( (Celecoxib 100mg Capsul | $94.2K | 4 |
What Micro Labs Limited must comply with to export Celecoxib to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | CIPLA LIMITED | $12.2M | 384 | 3 | $31.7K |
| 2 | MACLEODS PHARMACEUTICALS LTD | $9.2M | 184 | 21 | $50.0K |
| 5 | MICRO LABS LIMITED ★ | $6.8M | 201 | 19 | $33.8K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $3.6M | 149 | 15 |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 544 | 11.1% |
| DELHI AIR CARGO ACC (INDEL4) | 475 | 9.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 433 | 8.9% |
| SAHAR AIR | 323 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 305 | 6.3% |
| DELHI AIR | 256 | 5.2% |
| JNPT | 216 | 4.4% |
| MUNDRA SEA | 196 | 4.0% |
Micro Labs Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Visual overview of India's celecoxib supplier profile for Micro Labs Limited — top suppliers, destinations, pricing, and trade routes
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Celecoxib, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Celecoxib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
| GERMANY |
| $358.9K |
| 21 |
| E.P.DIS.,., | FRANCE | $255.4K | 6 |
| SARL LABORATOIRES MERINAL | ALGERIA | $208.3K | 5 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $200.8K | 6 |
| BROWN AND BURK LIMITED | UNITED KINGDOM | $179.3K | 7 |
Micro Labs Limited supplies Celecoxib to 37 buyers globally. The largest buyer is E.P.DIS (FRANCE), followed by AL-KAWKAB SCIENTIFIC BUREAU (JORDAN) and EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| CELECOXIB MICRO LABS 200MG HARTKAPSELN ( |
| $90.2K |
| 6 |
| CELECOXIB CAPSULES 200mg ( 500`S ) ( QTY- 2828.000 ) | $79.9K | 2 |
Micro Labs Limited exports 162 distinct Celecoxib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CELECOXIB CAPSULES 100 MG ANDA NO. 20477 with 5 shipments worth $209.6K.
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| $23.9K |
| 1 | UMEDICA LABORATORIES PRIVATE LIMITED | $3.3M | 65 | 2 | $50.0K |
Micro Labs Limited ranks #5 among 326 Indian Celecoxib exporters. Average shipment value of $33.8K compared to the market average of $192.8K. The closest competitors by value are CIPLA LIMITED and MACLEODS PHARMACEUTICALS LTD.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current shipment-level data, contact TransData Nexus.